1. From the Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, Texas;
2. Allergy and Asthma Center and Alpert Medical School of Brown University, East Providence, Rhode Island;
3. Clinical Development and Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut;
4. eMAX Health, White Plains, New York;
5. eMAX Health, Delray Beach, Florida; and
6. Division of Allergy and Immunology, Advocate Health Care, Chicago, Illinois